Wenyu Yang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Model-informed precision dosing of vancomycin in children 3 months to 18 years of age using Australia-wide data.
Journal: Antimicrobial agents and chemotherapy
Published: May 12, 2026
Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0 to 18 years.
Journal: International journal of antimicrobial agents
Published: October 19, 2025
Distribution of piperacillin-tazobactam into cerebrospinal, peritoneal, and pleural fluid in children aged 0-18 years.
Journal: International journal of antimicrobial agents
Published: October 19, 2025
Ivermectin dosing for children under 2 years.
Journal: The Journal of antimicrobial chemotherapy
Published: August 01, 2025
Identifying a therapeutic target for ganciclovir against cytomegalovirus in immunocompromised children.
Journal: British journal of clinical pharmacology
Published: July 08, 2025
Population Pharmacokinetics of Sacubitril/Valsartan in Patients with Heart Failure and End-Stage Renal Disease Undergoing Peritoneal Dialysis.
Journal: Clinical pharmacokinetics
Published: March 01, 2025
Optimized Sampling Strategies for Isoniazid in East Asian Pediatric Populations Using Population Pharmacokinetics-Informed Approaches.
Journal: Drug design, development and therapy
Published: November 11, 2024
Defining a Therapeutic Target for Ganciclovir Therapy in Immunocompromised Children With Cytomegalovirus Infection: A Brief Report.
Journal: The Pediatric infectious disease journal
Published: November 01, 2024
First-line serplulimab-based immunochemotherapy in elderly patients with extensive-stage small cell lung cancer: a multicenter, real-world study.
Journal: Journal of thoracic disease
Published: October 25, 2024
Evaluation of an optimized intermittent vancomycin dosing regimen in infants.
Journal: The Journal of antimicrobial chemotherapy
Published: October 15, 2024
Serum ganciclovir drug exposure in children receiving standard ganciclovir dosing.
Journal: Antimicrobial agents and chemotherapy
Published: September 18, 2024
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAFV600E mutation: a multi-center real-world experience in China.
Journal: Translational lung cancer research
Published: September 04, 2024
Last Updated: 09/26/2026